Novel vanillin derivatives: synthesis, anti-oxidant, DNA and cellular protection properties. by Scipioni, Matteo et al.
  
 
AUTHOR(S): 
 
 
TITLE:  
 
 
YEAR:  
 
Publisher citation: 
 
 
 
OpenAIR citation: 
 
 
 
Publisher copyright statement: 
 
 
 
 
 
OpenAIR takedown statement: 
 
 This publication is made 
freely available under 
________ open access. 
 
 
 
 
 
This is the ______________________ version of an article originally published by ____________________________ 
in __________________________________________________________________________________________ 
(ISSN _________; eISSN __________). 
This publication is distributed under a CC ____________ license. 
____________________________________________________
 
Section 6 of the “Repository policy for OpenAIR @ RGU” (available from http://www.rgu.ac.uk/staff-and-current-
students/library/library-policies/repository-policies) provides guidance on the criteria under which RGU will 
consider withdrawing material from OpenAIR. If you believe that this item is subject to any of these criteria, or for 
any other reason should not be held on OpenAIR, then please contact openair-help@rgu.ac.uk with the details of 
the item and the nature of your complaint. 
 
Accepted Manuscript
Novel vanillin derivatives: Synthesis, anti-oxidant, DNA and cellular protection
properties
Matteo Scipioni, Graeme Kay, Ian Megson, Paul Kong Thoo Lin
PII: S0223-5234(17)30975-3
DOI: 10.1016/j.ejmech.2017.11.072
Reference: EJMECH 9947
To appear in: European Journal of Medicinal Chemistry
Received Date: 13 September 2017
Revised Date: 20 November 2017
Accepted Date: 25 November 2017
Please cite this article as: M. Scipioni, G. Kay, I. Megson, P. Kong Thoo Lin, Novel vanillin derivatives:
Synthesis, anti-oxidant, DNA and cellular protection properties, European Journal of Medicinal
Chemistry (2017), doi: 10.1016/j.ejmech.2017.11.072.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
Graphical abstract 
Novel Vanillin Derivatives: Synthesis, anti-oxidant, DNA and Cellular protection properties  
Matteo Scipioni, Graeme Kay, Ian Megson, Paul Kong Thoo Lin 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Novel Vanillin Derivatives: Synthesis, anti-oxidant, DNA and Cellular protection properties  
Matteo Scipioni1, Graeme Kay1, Ian Megson2, Paul Kong Thoo Lin*1 
1School of Pharmacy and Life sciences, Robert Gordon University, Aberdeen, UK  
2 Department of Diabetes and Cardiovascular Science, UHI, Inverness, UK 
 
Abstract 
Antioxidants have been the subject of intense research interest mainly due to their beneficial 
properties associated with human health and wellbeing. Phenolic molecules, such as naturally 
occurring Resveratrol and Vanillin, are well known for their anti-oxidant properties, 
providing a starting point for the development of new antioxidants. Here we report, for the 
first time, the synthesis of a number of new vanillin through the reductive amination reaction 
between vanillin and a selection of amines. All the compounds synthesised, exhibited strong 
antioxidant properties in DPPH, FRAP and ORAC assays, with compounds 1b and 2c being 
the most active.  The latter also demonstrated the ability to protect plasmid DNA from 
oxidative damage in the presence of the radical initiator AAPH. At cellular level, 
neuroblastoma SH-SY5Y cells were protected from oxidative damage (H2O2, 400 µM) with 
both 1b and 2c. The presence of a tertiary amino group, along with the number of vanillin 
moieties in the molecule contribute for the antioxidant activity. Furthermore, the 
delocalization of the electron pair of the nitrogen and the presence of an electron donating 
substituent to enhance the antioxidant properties of this new class of compounds. In our 
opinion, vanillin derivatives 1b and 2c described in this work can provide a viable platform 
for the development of antioxidant based therapeutics. 
 
Keywords: Vanillin derivatives, Synthetic antioxidants, Antioxidant assays, Oxidative stress, DNA 
and Cell protection. 
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Introduction 
In recent years, antioxidants have been the subject of intense research interest mainly due to 
their beneficial properties associated to human health and wellbeing [1]. Oxidative stress, the 
imbalance between reactive oxygen and nitrogen species (ROS and RNS) production and the 
antioxidant defence, is well known to play a fundamental role in different pathophysiological 
conditions [2]. In fact, a strong link between age related diseases such as cancer, 
cardiovascular, immune and neurodegenerative disorders with oxidative stress has been 
recently found [3-5]. With an aging world population, the occurrence of these conditions is 
on the increase and therefore there is intense interest in the search and study for novel 
antioxidant molecules for their potential use as therapeutic agents [6]. Furthermore, new 
synthetic antioxidants can help to decipher the mode of action of many diseases associated 
with oxidative stress. In the last decade, Choi et al. showed the beneficial effect of an 
antioxidant-based therapy on cognitive decline in patients suffering from Alzheimer disease 
(AD) [7]. In addition, Takahata et al. reported on the strong link between oxidative stress and 
the lipid peroxidation occurring in Parkinson’s disease (PD), thus setting the basis for a 
possible antioxidant therapeutic approach [8]. Along with their potential therapeutic 
applications, the food industry uses popular synthetic antioxidants such as trolox, 
ethylvanillin, butylhydroxytoluene (BHT) and butylhydroxyaniline (BHA) to extend the shelf 
life of food products. Therefore, there is also high demand for new antioxidants in the food 
industry [9, 10].   
 
Although there have been many studies on the application of individual natural and synthetic 
polyphenolic compounds against cancer [11-13] and inflammatory conditions [14], there is 
limited information on the derivatives of vanillin. The latter is a phenolic compound widely 
available and applied in the food, drink and cosmetic industries [15, 16]. Furthermore it has 
been shown recently that vanillin exhibited neuroprotection ability in an experimental model 
of Huntington’s disease and ischemia mainly due to its antioxidant, anti-inflammatory, and 
anti-apoptotic properties [17]. Recently, Lee et al. reported the synthesis of a number of 
vanillin based dendrimers with enhanced antioxidant properties. They also found those 
dendrimers to have protective effects on fatty acid (linoleic acid), DNA (pBR322), and 
lipoprotein (human LDL) against free radical damage. [18, 19]. In other reports 
diarylpyrazole derivatives bearing a vanillinic hydrazine moiety, had been designed and 
synthesised to demonstrate both in vivo hypoglycemic and in vitro antioxidant activities. It 
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was also claimed that the presence of vanillinic group contributed to its radical scavenging 
properties [20, 21]. 
Here we report for the first time the synthesis and characterisation of a number of new 
vanillin derivatives (Scheme 1, 1a-1j, 2a-2f, 3 and 4); the determination of their in vitro 
antioxidant properties together with their structure activity relationship (SAR) analysis and 
their ability to protect DNA from free radical damage. The protection of hydrogen peroxide 
stressed human neuroblastoma cells with the most active antioxidant derivatives (1b, 2c) was 
also studied. 
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Results and discussion 
Chemical Synthesis 
The synthesis of a series of vanillin derivatives was achieved by reacting Vanillin with the 
corresponding amines under reductive amination conditions [22] (NaCNBH3, ZnCl2) in 
methanol to yield either the mono, di- or the tetra- vanillin derivatives in yields ranging from 
12-90% (see scheme 1).  
 
 
Scheme 1. Chemical strategy for the synthesis of Vanillin derivatives     
 
Depending on the ratio of the reagents used in each reaction, either the di- or tetra- vanillin 
derivatives were obtained. For example, in the synthesis of divanillin derivatives 1a-1f and 1i 
an excess of amines was required. The excess amine was removed by extracting with 
CHCl3/saturated NaHCO3 (the amines being water soluble together with NaCNBH4 and 
ZnCl2, were efficiently removed by the bicarbonate solution wash) or by column 
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chromatography (CHCl3/ MeOH 95:5). Interestingly, this reaction always yielded the di-N-
alkylated product (divanillin) rather than the mono-N-alkylated derivative. This finding will 
require further study and elaboration, but it was out with the scope of this work. For this 
reason, the synthesis of compound 4 was performed in a multistep reaction (see scheme 1); 
Compound 1 was obtained after the reaction of vanillin with an equimolar amount of amine 
to yield the corresponding imine which upon subsequent reduction, using sodium 
borohydride, afforded 4 in 68%. It is also of interest to note that only the N,N-divanillin 
derivative 1h was obtained following the same above mentioned strategy and no N1,N3-
disubstituted isomeric compound was obtained as a by-product. 
Interestingly, some of the crude compounds when purified by solvent extraction gave poorer 
yields (12-23%). This is due to the fact that these products are sparingly soluble in the 
aqueous phase. In contrast using column chromatography for purification of the crudes 
afforded higher yields (65-82%). For the synthesis of 1g, 1j, 2a-2f an excess of the aldehydic 
compound (2-3 equivalents) led to the production of the stoichiometrically desired 
compounds in good yields (38-90%) which precipitated out from the reaction solution except 
for compound 2b  (18%). All compounds were fully characterised by 1H and 13C NMR and 
high resolution mass spectroscopy (see experimental section and Supplementary 
Information, SI). 
 
Antioxidant activity 
All compounds synthesised were studied for their antioxidant properties using a range of 
assays with differing oxidative potential evaluating mechanisms. Furthermore, the ability of 
selected compounds to protect plasmid pBR322DNA from damage in the presence of the 
radical initiator AAPH was also studied. All the antioxidant results are listed in tables 1 and 2 
below.   
DPPH Assay 
Diphenyl-1-picrylhydrazyl (DPPH) is a stable organic nitrogen radical with an absorption 
maximum at 515nm. Its reduction in the presence of antioxidants was monitored 
spectrophotometrically [23]. The IC50 value of each compound was determined (see table 1 
and Supplementary Information, SI). All the Vanillin derivatives except 1h, 2a and 2e 
showed strong radical scavenging activity with IC50 ranging from 5.8 to 248 µM when 
compared with the starting compounds used in the synthesis i.e. vanillin and syringaldehyde 
(IC50 4050 and 1150 µM respectively). Interestingly the majority of the compounds 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
synthesised, showed similar range of activity to known antioxidant Trolox (IC50 27.6 µM) 
[19]. 
 
Table 1. Antioxidant properties of vanillin derivatives 1a-1j, 2a-2e, 3 and 4. 
Compound 
 
DPPH (IC50 µM) 
 
FRAP (TE) 
 
1a 12.77 ± 0.11 
 
0.62 ± 0.05 
1b 13.65 ± 0.15 
 
0.68 ± 0.02 
1c 21 ± 0.40 
 
0.62 ± 0.03 
1d 24 ± 2.00 
 
0.63 ± 0.03 
1e 22.20 ± 0.60 
 
0.64 ± 0.02 
1f 21.90 ± 1.70 
 
0.60 ± 0.01 
1g 29.70 ± 1.30 
 
0.55 ± 0.05 
1h INACTIVE* 
 
0.28 ± 0.02 
1i 12.30 ± 1.20 
 
1.14 ± 0.04 
1j 15.38 ± 1 
 
1.11 ± 0.03 
2a INACTIVE* 
 
2.54 ± 0.56 
2b 137.50 ± 5.50 
 
0.56 ± 0.05 
2c 5.80 ± 0.10 
 
5.29 ± 0.62 
2d 144.30 ± 34.70 
 
2.81 ± 0.45 
2e INACTIVE* 
 
0.74 ± 0.13 
2f 
 
98 ± 5.51 2.78 ± 0.03 
3 248.5 ± 24.50 
 
0.06 ± 0.003 
4 107 ± 1 
 
0.16 ± 0.08 
Vanillin 4050 ± 25 
 
0.11 ± 0.07 
Syringaldehyde 1150 ± 22 
 
0.93 ± 0.03 
Results from each assay are expressed as a mean ± SD of three independent experiments.*Compounds were 
tested up to 250 µM.  
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Compounds 1a, 1b, 1c, 1d, 1e and 1f all exhibited similar activity (IC50 ranging from 12.77 
to 22.2 µM), confirming that the nature of the alkyl chain has no effect on the antioxidant 
activity. Furthermore, it is interesting to note that the terminal functional group does not have 
any impact on antioxidant activity. For example, 1c has a terminal hydroxyl group whereas 1f 
has a methyl group, both compounds demonstrated similar range of antioxidant properties 
with IC50 values of 13.65 to 21.9 µM respectively.  
 It can clearly demonstrated that the structural feature contributing to the greatest impact on 
the radical scavenging property was the basicity of the nitrogen in the molecule. This is 
evident when comparing the activity of compounds 3, 4 and 1g (IC50 248.5, 107 and 29.7 µM 
respectively) with 1g bearing a tertiary amine, showed greater activity when compared to the 
secondary amine 4 and the imine 3. Furthermore, quaternary salts 1h and 2e were devoid of 
any activity, suggesting the importance of the electron pair on the nitrogen atoms for radical 
scavenging property. In addition, the number of vanillin moieties present in each molecule 
had a significant effect on the antioxidant activity of each compound. For example 2c has 4 
vanillin moieties and is almost 2 times more active than 1b, which has only two vanillin 
moieties (IC50 5.8 and 13.65 µM respectively). 
 
Compounds with a syringaldehyde moiety such as 1j (an extra methoxy group when 
compared with vanillin) showed an increase in activity when compared with the 
corresponding vanillin derivative 1g with IC50 values of 15.38 and 29.7 µM respectively, thus 
highlighting the role of the extra methoxy group in the aromatic structure. At the same time, 
removal of the methoxy group caused a dramatic reduction of activity as shown in 
compounds 2c and 2f (5.8 and 98 µM respectively). Finally, as expected the presence of a 
hydroxyl group in the vanillin moiety plays a fundamental role in antioxidant activity [24]. 
This is clearly demonstrated with compound 2a which bears no hydroxyl group, exhibited no 
activity and this is compared with hydroxylated compound 2f (98 µM). Interestingly, the 
substitution of the phenyl ring of 2c with a cyclohexane ring (2b) also caused a dramatic loss 
of antioxidant activity (5.8 and 137.5 µM respectively).  
 
FRAP Assay 
The FRAP assay works at acidic pH and is based on the reduction of the ferric-
tripyridyltriazine complex by antioxidants. The resulting formation of the ferrous-
tripyridyltriazine complex leads to a measurable blue colour (593 nm) [25] and the results are 
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expressed as Trolox Equivalent (TE) (see SI) by direct comparison with the standard trolox 
calibration curve. All the derivatives synthesised, showed significantly increase (up to 48 
times) in activity in the FRAP assay (0.16- 5.29 TE) when compared with vanillin (0.11 TE) 
except for compound 3 (imine derivative, 0.06 TE). No statistical differences in activity were 
found for the derivatives bearing different alkyl chain linked to the basic nitrogen (1a-1g) 
with values ranging from 0.55-0.68 TE. 
As in the above DPPH assay the presence of  the basic nitrogen in the molecule provides 
some impact on the antioxidant activity as evidenced by comparing compounds 3 (imine), 4 
(2o amine) and 1g (3o amine) showing a gradual increase in FRAP activity with 0.06, 0.16 
and 0.55 TE respectively. Furthermore, the dihydrochloride salts 1h and 2e showed weak 
FRAP activity with 0.28 and 0.74 TE respectively. On the other hand, syringaldehyde 
derivatives showed improved activity (almost two times) when compared with the 
corresponding vanillin derivatives, as evidenced with 1j with 1g, 1.11 and 0.55 TE 
respectively and 1i with 1b, 1.14 and 0.68 TE respectively. However, the increase in activity 
of syringaldehyde derivatives does not follow the same trend of syringaldehyde itself when 
compared with vanillin (0.93 and 0.11 TE, respectively). 
 
Compounds 2c, 2d, 2f and 2a showed the highest activities with 5.29, 2.81, 2.74 and 2.54 TE 
respectively, thus highlighting the importance of the number of vanillin moieties and the 
presence of both hydroxyl and methoxy groups in the molecule. Compounds bearing only 
hydroxy (2f), methoxy (2a) groups and no substituents on the aromatic ring (2d) showed 
similar activity (2.78, 2.54 and 2.81 TE, respectively). When both hydroxy and methoxy 
substituents are present at the same time on the aromatic ring (2c), this enhances the activity 
of the compound (5.29 TE). Interestingly, the substitution of the phenyl ring in 2c with a 
cyclohexane ring 2b resulted in a dramatic loss in antioxidant activity (5.29 and 0.74 TE 
respectively). For that reason, in contrast to the DPPH assay, the delocalization of the 
nitrogen’s electrons onto the aromatic ring linking the vanillin /syringaldehyde moieties 
appears to be fundamental for enhanced antioxidant activity. It is of note that 2b exhibited 
comparable FRAP activity to compounds 1a-1i, all the latter compounds are not able to 
delocalize the tertiary amino electrons due to the absence any conjugated system linking 
vanillin /syringaldehyde moieties (see Figure 4).  
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ORAC Assay 
The ORAC assay is based on hydrogen atom transfer and measures the capacity of a 
compound to inhibit the peroxyl free radical induced oxidation of fluorescein. The thermal 
decomposition of the oxidative stress inducer AAPH results in the formation of free radicals, 
emulating that found commonly in the human body. Thus making this assay more relevant to 
biological systems [26]. 
Only a selection of compounds was put through the ORAC assay (see table 2). The selection 
(1b, 1g, 1h, 2c, 2e, 3, 4) was based on the number of vanillin moieties and the results from 
the previous antioxidant assays. 
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Table 2. Antioxidant properties of selected vanillin derivatives. 
Compound 
 
ORAC (TE) 
 
DNA Protection (IC50 µM) 
 
1b 6.02 ± 0.56 
 
3.60 ± 0.87 
 
1g 5.34 ± 1.54 
 
3.80 ± 1.40 
 
1h 4.08 ± 0.82 
 
61.50 ± 5.20 
 
2a INSOLUBLE 13.60 ± 1.20 
 
2c 20.40 ± 1.30 
 
0.60 ± 0.10 
 
2e 7.54 ± 1.25 
 
13.90 ± 4.20 
 
3 1.85 ± 0.90 
 
3.80 ± 1.20 
 
4 3.16 ± 1.15 
 
4.10 ± 1.90 
 
Vanillin 2.19 ± 0.28 
 
5.60 ± 0.60 
 
Syringaldehyde 1.45 ± 0.12 
 
9.50 ± 0.30 
 
Results from each assay are expressed as a mean ± SD of three independent experiments.  
 
All the derivatives showed increased activity with the ORAC assay compared with the 
starting compound vanillin (2.19 TE) except the imine derivative 3 (1.85 TE) (see table 2). 
The different types of alkyl chains has no effect on the activity in this assay. For example 1b 
and 1g showed similar activity (6.02 and 5.34 TE respectively); however, the number of 
vanillin moieties in the molecule appears to contribute significantly in the activity, since 
compound 1g showed to be 2 fold more active than 4. At the same time, compound 4 (a 2o 
amine) showed increased activity when compared with 3 (imine), confirming the importance 
of the nitrogen basicity as discussed above. In contrast to the DPPH and FRAP assays the 
hydrochloride salts 1h and 2e, turned out to be active in the ORAC assay with 4.08 and 7.54 
TE respectively. This may be due to the weakly basic (pH 7.4) environment the experiment 
was carried out. Compound 2c showed the highest activity (20.4 TE), highlighting the 
importance of the number of vanillin moieties in the molecule. 
 
DNA Damage Protection Assay 
The same set of compounds used in the ORAC assay was applied to the DNA damage 
protection assay. As previously demonstrated in the ORAC assay above, AAPH has the 
ability to reduce fluorescence intensity of the used fluorescence probe, caused by radical 
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generation. AAPH is also able to cause oxidative DNA stand breakage in pBR322 plasmid 
DNA [27], from the supercoiled to both opened circular and linear form of the plasmid DNA. 
Previous work had demonstrated natural compounds such as phenolic extracts from 
Sphallerocarpus gracilis seeds are able to prevent plasmid DNA strand break. [28] Here all 
the derivatives tested, showed better activity in protecting oxidative DNA damage when 
compared with vanillin (IC50 5.6 µM, see table 2) except for derivatives 1h, 2a and 2e which 
gave IC50 values of 61.5, 13.6 and 13.9 µM respectively. Both of the hydrochloride salts 
showed lower activity (IC50 values 61.5 and 13.9 µM respectively), confirming the 
importance of the electron pair on the nitrogen atoms for enhanced activity. For example in 
Figure 1, DNA protection can be observed with much higher vanillin concentration (34µM) 
while with 2c only a concentration of 4µM was required to obtain maximum DNA protection 
(figure 1). Furthermore, while vanillin at 2.2µM concentration showed no protective effect, 
2c (at 0.11µM) on the other hand showed 14.7% DNA protection.  
 
Figure 1. Gel image obtained after DNA protection assay for vanillin (above) and compound 2c (below). The 
first band (c) at the base represents the DNA control; the band (AAPH) is the AAPH control, the bands from (34 
– 2.2 µM) and from (4.0 – 0.11 µM) represent the DNA protection for different concentrations of the 
compounds. The intensity of each band was measured with image J software and the percentage of protection 
was measured for each concentration.           
 
The substitution of the OH group with an H atom in the vanillin moieties caused a dramatic 
reduction of activity as shown in compounds 2a (IC50 13.6 µM) and 2c (IC50 0.6 µM). 
Although the type of alkyl chain (1b, IC50 3.6 and 1g, IC50 3.8 µM) showed no effect on 
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activity,  the number of vanillin moieties in the molecule however plays a crucial role on the 
activity as seen in derivative 2c which bears four vanillin moieties (IC50 0.6 µM). 
Interestingly in this assay no statistically difference in activity between imine 3 and its 
corresponding reduced form 4 was showed (IC50 3.8 and 4.1 µM respectively). 
 
Cellular protection through MTT assay 
3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assay is a colorimetric 
experiment to study cell viability. In this study, the protective potential of 1b and 2c was 
investigated using the neuroblastoma SH-SY5Y human derived cell line. In many age related 
diseases, cell death is often induced by the presence of Reactive Oxygen Species (ROS). Here 
H2O2 (400 µM) was used as a model neurotoxin since it gives rise to oxidative stress in SH-
SY5Y cells followed by cell death. [29] 
Compounds 1b and 2c were chosen in this assay due their strong antioxidant activities 
demonstrated in the different assays discussed above. Compounds 1b and 2c did not show 
cellular cytotoxicity up to 1 mM and 20 µM respectively (see SI).  Therefore the ability of 1b 
to protect H2O2 (400 µM) treated cells, at concentrations ranging from 0.1 – 200 µM and for 
2c from 0.01-10.00 µM were studied. From Figure 2, it can clearly be seen that 1b 
significantly protected (6%) stressed cells at concentration as low as 5 µM (p < 0.05). 
Maximum cellular protection (20%) was achieved with 200 µM of 1b (p < 0.001). 
 
Similarly from figure 2, compound 2c significantly protected (8%) H2O2 (400µM) stressed 
cells at a much lower concentration of 0.1 µM (p < 0.01) and the maximum cellular 
protection (30%) was achieved at 10 µM (p < 0.001) which is well below the cytoxicity 
concentrations of 2c. Therefore 2c is 20 times better at protecting H2O2 (400µM) stressed 
cells than 1b. It is noteworthy to mention that vanillin itself up to 800 µM concentration did 
not show any protection on H2O2 (400 µM) stressed cells (see SI).  
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Figure 2. Protective effects of compound 1b and 2c in hydrogen peroxide (400µM)-stressed cells. Cells were 
incubated with 1b (0.1-200µM) or 2c (0.01-10µM) for 24 hours before the addition of hydrogen peroxide. After 
24 hours the cell viability was measured using the MTT assay. Values are expressed as the percentage of the 
untreated control and represented as mean ± SD of three independent experiments in each group. ***p<0.001, 
**p<0.01, *p<0.05, ns no significantly different compared to the control. 
 
SAR 
Different antioxidant assays were performed on all the compounds synthesised to evaluate 
their antioxidant properties and to determine a structure-activity relationship (SAR). For 
enhanced antioxidant properties the presence of the following are important (see figure 3): (i) 
tertiary amine (ii) phenolic functionality (iii) the number of vanillin moiety (iv) electronic 
delocalisation. 
                                             
 
Figure 3. SAR study for new derivatives. The key features for the antioxidant activity are highlighted in different 
colours: vanillin moiety (blue), phenolic functionality (yellow), tertiary amine (red) and electronic 
delocalisation (purple).  
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The most interesting antioxidant compounds 1b and 2c showed their ability to protect 
plasmid DNA from radical damage with IC50 values 3.6 and 0.6 µM, respectively. Compound 
2c exhibited total DNA protection up to concentration of 4 µM, demonstrating improved 
activity compared with other synthetic compounds derived from natural occurring antioxidant 
resveratrol [30]. Interestingly a homologue compound of 2c reported by Lee et al. [19] with a 
benzyl group linking the four vanillin moieties A (figure 4) instead of a phenyl group as in 
the case of 2c (0.6 µM) showed much weaker DNA protection activity at concentration > 45 
µM. Therefore the ability for the lone pair of electrons on the tertiary amino group to 
delocalise towards the phenyl group may be a contributory factor for increased antioxidant 
activity. 
 
NN
OH
OHHO
HO
OCH3
H3CO
OCH3
OCH3
CC
H
H
H
H
A         
 
 
Figure 4. Benzyl Vanillin derivative, A [19] and Phenyl Vanillin derivatives, 2b and 2c. The nitrogen’s electron 
pairs cannot be delocalized in the cyclic system nearby (compound A and 2b). However, delocalization is 
possible for compound 2c. 
 
In a more complex cell based assay both 1b and 2c demonstrated cellular protection of H2O2 
treated neuroblastoma cells with 2c exhibiting some protection at drug concentration as low 
as 0.01 µM. Furthermore 1b and 2c showed an increase in the cell viability of almost 20% 
and 30% at concentrations of 200 µM and 10 µM respectively. Our results showed similar 
antioxidant effects when compared to huperzine A (10 µM), a naturally occurring 
sesquiterpene alkaloid compound. The latter is a cholinesterase inhibitor well-known for its 
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protective effects on hydrogen peroxide-stressed cells and is currently undergoing phase I 
trial for Alzheimer disease treatment. [31-32]  
 
Conclusions 
A structurally related series of vanillin derivatives were synthesized using reductive 
amination methodology. The yields of the reaction ranged from 12-90 %. Depending on the 
assay used, the majority of the compounds exhibited from good to very good antioxidant 
properties.  Based on the results we have presented so far, the mechanism of DNA or/and 
cellular protection can either be via direct antioxidant activity or by upregulation of 
antioxidant defences. In the case of DNA protection assay, since this is an in vitro set up, 
most likely, the compounds (2c and 1b) tested, acted as radical scavenging agent.  However 
in the cellular assay, both mechanisms are possible.  We are currently addressing these 
important questions at cellular levels and our findings will be reported elsewhere. Taken 
together the vanillin derivatives reported in this work can provide a viable platform in the 
development of antioxidant based therapeutics. [33] 
Experimental Section 
All the reagents and solvents were purchased from Sigma-Aldrich and Fisher Scientific 
unless otherwise stated.  All 1H and 13C spectra were collected using a Magnet Ultrashield 
Bruker 400 MHz. High-resolution Mass spectrometry was performed at EPSRC National 
Mass Spectrometry Service Centre at Swansea University, Swansea using Thermo Scientific 
LTQ Orbitrap XL or Waters Xevo G2-S spectrometers. The progress of each reaction was 
monitored by thin layer chromatography (TLC Aluminium foil silica gel 60 with fluorescence 
indicator 254 nm, Sigma-Aldrich) viewed under UV light (254-265 nm).  Column 
chromatography was carried using silica gel (Alfa Aesar 70-230 mesh) as stationary phase 
and chloroform/methanol as mobile phase. The chemical drawing and nomenclature of the 
compounds were applied according to ChemBioDraw Ultra version 13.0 (CambridgeSoft). 
Neuroblastoma SH-SY5Y cells were from the European Collection of Authenticated Cell 
Cultures (ECACC). Cells were maintained in DMEM medium (containing GlutaMAX-1 with 
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25 mM HEPES), supplemented with 10% (v/v) Foetal Bovine Serum (FBS) and 1% 
Penicillin/Streptomycin (10,000 µg/mL). Cells were grown at 37oC (5% CO2). GelRed™ 
Nucleic Acid Gel Stains 10000x in water (Biotium) was from VWR.  
General Method 
All the Vanillin derivatives (1a-1j, 2a-2e) were obtained through the reductive amination in a 
one pot reaction as previously reported (with modifications). [34] In general a mixture of 
Vanillin, Syringaldehyde or Benzaldehyde and the corresponding amine or diamine were 
dissolved in methanol followed by the addition of NaCNBH3 and ZnCl2. The reaction 
mixture was stirred overnight at room temperature. After the reaction was completed 
(monitored by tlc), it was evaporated to dryness using a rotary evaporator, then the residue 
was dissolved in chloroform followed by extraction with saturated NaHCO3 (x 3). The 
organic fraction was dried with anhydrous sodium sulphate, filtered and the solvent removed 
under vacuo to yield the final products. In some cases as indicated in the method section, the 
crude products were directly subjected to column chromatography (CHCl3/ MeOH 95:5) to 
give pure products. In other reactions, when the reaction was complete, the product 
precipitated out of solution. The resulting precipitate was collected by filtration, washed 
thoroughly and dried under vacuo.  
Synthesis of 4,4'-(((2-hydroxyethyl)eazanediyl)bis(methylene))bis(2-methoxyphenol)- 1a 
Vanillin (1g, 6.6 mmol) and 2-aminoethanol (0.30 ml, 5 mmol) in presence of NaCNBH3 (1.2 
equiv.) and ZnCl2 (1.2 equiv.) in methanol afforded 1a in 12 % yield as a thick orange oil 
after extraction with CHCl3 and saturated NaHCO3. 1HNMR: (CDCl3 solvent peak δ:7.21), 
6.76-6.67 (m, Ar-H, 6H), 3.75 (s, -OCH3, 6H),  3.50 ( t, CH2-CH2-OH, J = 5.6 Hz, 2H), 3.45 
(s, Ar-CH2-N, 4H), 2.57  (t, N-CH2-CH2, J = 5.6 Hz, 2H). 13CNMR: (CDCl3 solvent peak δ: 
77.4-76.8), 146.8-111.2, 58.5, 57.9, 56.0, 54.6. HRMS calcd for C18H24NO5 [M+H]+ 
334.1649, m/z found 334.1648. 
Synthesis of 4,4'-(((3-hydroxypropyl)azanediyl)bis(methylene))bis(2-methoxyphenol)- 1b 
Vanillin (1 g, 6.6 mmol) and 3-amino-1-propanol (0.326 ml, 5 mmol) in presence of 
NaCNBH3 (1.2 equiv.) and ZnCl2 (1.2 equiv.) in methanol afforded 1b in 70% yield as a 
thick orange oil after column chromatography of the crude. 1HNMR: (CDCl3 solvent peak 
δ:7.21), 6.82-6.72 (m, Ar-H, 6H), 3.83 (s, -OCH3, 6H), 3.63 (t, CH2-CH2-OH, J = 5.2 Hz, 
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2H), 3.45 (s, Ar-CH2-N, 4H), 2.60 (t, N-CH2-CH2, J = 5.6 Hz, 2H), 1.72 (m, CH2-CH2-CH2, 
2H). 13CNMR: (CDCl3 solvent peak δ: 77.6-74.8), 147.0-110.7, 64.3, 58.4, 55.9, 53.3, 27.4. 
HRMS calcd for C19H26NO5 [M+H]+ 348.1805, m/z found 348.1801.  
Synthesis of 4,4'-(((4-hydroxybutyl)azanediyl)bis(methylene))bis(2-methoxyphenol)- 1c 
Vanillin (1 g, 6.6 mmol) and 4-amino-1-butanol (0.461 ml, 5 mmol) in presence of 
NaCNBH3 (1.2 equiv.) and ZnCl2 (1.2 equiv.) in methanol afforded 1c in 14 % yield as a 
thick orange oil after extraction with CHCl3 and saturated NaHCO3. 1HNMR: (CDCl3 solvent 
peak δ:7.21), 6.83-6.70 (m, Ar-H, 6H), 3.80 (s, -OCH3, 6H), 3.65 (s, Ar-CH2-N, 4H), 3.51 (t, 
CH2-CH2-OH, J = 5.6 Hz, 2H), 2.64 (t, N-CH2-CH2, J = 5.6 Hz, 2H), 2.38 (m, CH2-CH2-
CH2, 2H), 1.60 (m, CH2-CH2-CH2, 2H). 13CNMR: (DMSO solvent peak δ: 40.6-39.3), 147.8-
112.8, 60.5, 56.1, 46.8, 29.9, 23.3. HRMS calcd for C20H28NO5 [M+H]+. 362.1962, m/z found 
362.1962. 
Synthesis of 4,4'-(((5-hydroxypentyl)azanediyl)bis(methylene))bis(2-methoxyphenol)- 1d 
Vanillin (1 g, 6.6 mmol) and 5-amino-1-pentanol (0.326 ml, 5 mmol) in presence of 
NaCNBH3 (1.2 equiv.) and ZnCl2 (1.2 equiv.) in methanol afforded 1d in 82% yield as thick 
orange oil after column chromatography. 1HNMR: ((CD3)2SO solvent peak δ:2.52-2.50), 
(H2O 3.38), 6.90-6.78 (m, Ar-H, 6H), 3.99 (s, Ar-CH2-N, 4H), 3.75 (s, -OCH3, 6H), 2.81 (t, 
CH2-CH2-OH, J = 6.4 Hz, 2H),  2.50 (t, N-CH2-CH2, J = 6.4 Hz, 2H), 1.63 (m, CH2-CH2-
CH2, 2H), 1.41 (m, CH2-CH2-CH2, 2H), 1.35 (m, CH2-CH2-CH2, 2H). 13CNMR: 147.7-113.8, 
61.2, 57.2, 55.9, 50.7, 46.5, 30.6, 25.2, 22.2. HRMS calcd for C21H230NO5 [M+H]+ 376.2118, 
m/z found 376.2108. 
Synthesis of 4,4'-(((6-hydroxyhexyl)azanediyl)bis(methylene))bis(2-methoxyphenol)- 1e 
Vanillin (1 g, 6.6 mmol) and 6-amino-1-hexanol (0.59g, 5 mmol) in presence of NaCNBH3 
(1.2 equiv.) and ZnCl2 (1.2 equiv.) in methanol afforded 1e in 17 % yield as thick orange oil 
after extraction with CHCl3 and saturated NaHCO3. 1HNMR: (CDCl3 solvent peak δ:7.22), 
6.83-6.62 (m, Ar-H, 6H), 3.76 (s, -OCH3, 6H), 3.48 (t, CH2-CH2-OH, J = 6.8 Hz, 2H), 3.38 
(s, Ar-CH2-N, 4H), 2.68 (t, N-CH2-CH2, J = 6.8 Hz, 2H), 1.62 (m, CH2-CH2-CH2, 2H), 1.56 
(m, CH2-CH2-CH2,  2H), 1.32 (m, CH2-CH2-CH2, 2H), 1.28 (m, CH2-CH2-CH2, 2H). 
13CNMR: (CDCl3 solvent peak δ: 77.5-76.9), 147.2-110.1, 67.8, 61.4, 58.2, 55.2, 33.0-27.3. 
HRMS calcd for C22H32NO5 [M+H]+  390.2275 , m/z found 390.2272. 
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Synthesis of 4,4'-((butylazanediyl)bis(methylene))bis(2-methoxyphenol)- 1f 
Vanillin (1 g, 6.6 mmol) and n-butylamine (0.5ml, 5mmol) in presence of NaCNBH3 (1.2 
equiv.) and ZnCl2 (1.2 equiv.) in methanol afforded 1f in 23 % yield as a thick orange oil 
after extraction with CHCl3 and saturated NaHCO3. 1HNMR: (CDCl3 solvent peak δ:7.20), 
6.81-6.63 (m, Ar-H, 6H), 3.73 (s, Ar-CH2-N, 4H), 3.64 (s, -OCH3, 6H), 2.57 (t, N-CH2-CH2, 
J = 7.2 Hz, 2H), 1.42 (m, CH2-CH2-CH2, 2H), 1.25 (m, CH2-CH2-CH3, 2H), 0.94 (t, CH2-
CH3, J = 6.8 Hz, 3H). 13CNMR: (CDCl3 solvent peak δ: 77.8-76.7), 146.6-110.8, 55.8, 49.2, 
32.2-20.5. HRMS calcd for C20H27NO4  [M+H]+ 346.2013, m/z found 346.2013. 
Synthesis of 4,4'-((benzylazanediyl)bis(methylene))bis(2-methoxyphenol)- 1g 
Vanillin (1.5 g, 10mmol) and benzylamine (0.55 ml, 5 mmol) in presence of NaCNBH3 (1.2 
equiv.) and ZnCl2 (1.2 equiv.) in methanol gave a precipitate which after filtration, washing 
with deionized water and methanol, afforded 1g in 90 % yield. 1HNMR: ((CD3)2SO solvent 
peak δ:2.42-2.40), (H2O, 3.26), 7.30-6.59 (m, Ar-H, 11H), 3.67 (s, -OCH3, 6H), 3.56 (s, Ar-
CH2-N, 2H), 3.47 (s, Ar-CH2-N, 4H), 13CNMR: ((CD3)2SO solvent peak δ: 40.6-39.3), 
141.34-115.5, 55.9, 52.5, 45.6. HRMS calcd for C23H26NO4 [M+H]+ 380.1856, m/z found 
380.1849. 
Synthesis of N1,N1-bis(4-hydroxy-3-methoxybenzyl)propane-1,3-diaminium chloride- 1h 
 
Vanillin (1 g, 6.6 mmol) and 1,3 diaminopropane (0.84 ml, 10 mmol) in presence of 
NaCNBH3 (1.2 equiv.) and ZnCl2 (1.2 equiv.) in methanol afforded a precipitate which was 
filtered and washed with deionized water and methanol. Suspension of the precipitate in 
methanol (5 mL) followed by the addition of concentrated hydrochloric acid, gave a solid. All 
the solvent was removed using a rotary evaporator and the resulting solid washed with diethyl 
ether and dried under vacuo to yield  1h  (67%) as a white solid. 1HNMR: ((CD3)2SO solvent 
peak δ:2.51) (H2O, 3.64), 7.12-6.79  (Ar-H, 6H), 4.00 (s, Ar-CH2-N, 4H), 3.78 (s, -OCH3, 
6H), 2.95 (t, N-CH2-CH2, J = 7.6 Hz, 2H), 2.87 (t, CH2-CH2-NH3+ J = 7.6 Hz, 2H), 1.92 (m, 
CH2-CH2-CH2, 2H). 13CNMR 147.6-113.8, 55.9, 51.0, 43.6, 36.5, 23.7. HRMS calcd for 
C19H26ClN2O4 347.1965 [M-H2Cl]+, m/z found 347.1965. 
Synthesis of 4,4'-(((3-hydroxypropyl)azanediyl)bis(methylene))bis(2,6-dimethoxyphenol)- 1i 
Syringaldehyde (0.5 g, 2.7 mmol) and 3-amino-1-propanol (0.1 ml, 1.7 mmol) in presence of 
NaCNBH3 (1.2 equiv.) and ZnCl2 (1.2 equiv.) in methanol afforded 1b in 65% yield as thick 
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colourless oil after column chromatography. 1HNMR: (MeOD solvent peak δ:3.34), 6.81 (s, 
Ar-H, 4H), 4.17 (s, Ar-CH2-N, 4H), 3.84 (s, -OCH3, 12H), 3.73 (t, CH2-CH2-OH, J = 5.6 Hz, 
2H), 3.23 (t, N-CH2-CH2, J = 5.6 Hz, 2H), 1.97 (m, CH2-CH2-CH2, 2H), 13CNMR: (MeOD 
solvent peak δ: 48.2), 149.0-106.8, 59.4, 55.7, 51.6, 45.6, 28.2. HRMS calcd for C21H30NO7 
[M+H]+ 408.2017, m/z found 408.2012. 
Synthesis of 4,4'-((benzylazanediyl)bis(methylene))bis(2,6-dimethoxyphenol)- 1j 
Syringaldehyde (1 g, 5.4 mmol) and benzylamine (0.2 ml, 1.8 mmol) in presence of 
NaCNBH3 (1.2 equiv.) and ZnCl2 (1.2 equiv.) in methanol, gave a precipitate which was 
filtered and washed  with deionized water and methanol and dried to afford 1j in 46 % yield. 
1HNMR: ((CD3)2SO solvent peak δ:2.40), (H2O, 3.25), 7.28-6.48 (m, Ar-H, 9H), 3.64 (s, -
OCH3, 12H), 3.56 (s, Ar-CH2-N, 4H), 3.46 (s, Ar-CH2-N, 2H),. 13CNMR: ((CD3)2SO solvent 
peak δ: 40.6-39.3), 140.3-127.0, 56.3, 45.4. HRMS calcd for C25H30NO6 [M+H]+ 440.2058, 
m/z found 440.2058.
 
 
Synthesis of N1,N1,N4,N4-tetrakis(3-methoxybenzyl)benzene-1,4-diamine – 2a 
m-Anisaldehyde (0.82 g, 6 mmol) and p-Phenylendiamine (0.1 g, 1 mmol) in presence of 
NaCNBH3 (1.2 equiv.) and ZnCl2 (1.2 equiv.) in methanol afforded a precipitate which upon 
filtration, washed with deionized water and methanol and drying gave 2a in 54 % yield. 
1HNMR: (CDCl3 solvent peak δ: 6.81), 7.38-7.33 (m, Ar-H, 4H), 7.01-6.89 (m, Ar-H, 16H), 
4.62 (s, Ar-CH2-N, 8H) 3.87 (s, -OCH3, 12H). 13CNMR: (CDCl3 solvent peak δ: 77.6-77.0), 
160.0-112.2, 55.5, 55.2. HRMS calcd for C38H41N2O4 [M+H]+ 589.3061, m/z found 
589.3047. 
Synthesis of 4,4',4'',4'''-((((1r,4r)-cyclohexane-1,4-
diyl)bis(azanetriyl))tetrakis(methylene))tetrakis(2-methoxyphenol) – 2b 
Vanillin (1.82 g, 12 mmol) and trans-1,4-diaminocyclohexane (0.2 g, 2 mmol) in presence of 
NaCNBH3 (1.2 equiv.) and ZnCl2 (1.2 equiv.) in methanol afforded a precipitate which after 
filtration and washing with methanol to give a solid. The latter was dissolved in water, 
filtered and extracted with chloroform. The water phase was subjected to freeze drying to 
yield 2b (18 %). 1HNMR: ((CD3)2SO solvent peak δ:2.40 ), (H2O, 3.26),  7.10-6.67 (m, Ar-H, 
12H), 3.88 (s, Ar-CH2-N, 8H), 3.68 (s, -OCH3, 12H), 2.79 (m, N-CH-(CH2)2, 2H), 2.10 (m, 
CH-CH2-CH2, 4H), 1.30 (m, CH-CH2-CH2, 4H). 13CNMR: ((CD3)2SO solvent peak δ: 39.9-
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39.0), 148.0-114.4, 56.2, 55.0, 48.2, 27.3. HRMS calcd for C38H47N2O8 [M+H]+ 659.3327, 
m/z found 659.3327. 
Synthesis of 4,4',4'',4'''-((1,4-phenylenebis(azanetriyl))tetrakis(methylene))tetrakis(2-
methoxyphenol) – 2c 
Vanillin (1 g, 6.6 mmol) and p-Phenylenediamine (0.1 g, 1 mmol) in presence of NaCNBH3 
(1.2 equiv.) and ZnCl2 (1.2 equiv.) in methanol afforded a precipitate which was filtered and 
washed with deionized water and methanol. The solid was then dissolved in chloroform and 
extracted with saturated NaHCO3. The organic phase was dried and evaporated to dryness to 
give 2c in 74 % yield. 1HNMR: (CDCl3 solvent peak δ: 7.30), 6.88-6.76 (m, Ar-H, 16H), 4.39 
(s, Ar-CH2-N, 8H), 3.83 (s, -OCH3, 12H). 13CNMR: (CDCl3 solvent peak δ: 77.4-76.7), 
164.5-109.9, 55.9, 55.1. HRMS calcd for C38H41N2O8 [M+H]+ 653.2857, m/z found 
653.2851. 
Synthesis of N1,N1,N4,N4-tetrabenzylbenzene-1,4-diamine – 2d 
Benzaldehyde (1.27 g, 12 mmol) and p-Phenylenediamine (0.2 g, 2 mmol) in presence of 
NaCNBH3 (1.2 equiv.) and ZnCl2 (1.2 equiv.) in methanol afforded a precipitate which was 
filtered and washed with deionized water and methanol. The solid was then dissolved in 
chloroform and extracted with saturated NaHCO3. The organic phase was dried and 
evaporated to dryness to afford 2d in 80 % yield. 1HNMR: (CDCl3 solvent peak δ: 7.25), 
7.40-7.25 (m, Ar-H, 20H), 6.68 (s, Ar-H, 4H), 4.55 (s, Ar-CH2-N, 8H). 13CNMR: (CDCl3 
solvent peak δ: 77.4-76.7), 141.7-114.77, 55.1. HRMS calcd for C34H32N2 [M]+ 468.2560, 
m/z found 468.2550.  
Synthesis of N1,N1,N3,N3-tetrakis(4-hydroxy-3-methoxybenzyl)propane-1,3-diaminium 
chloride – 2e 
Vanillin (1.8 g, 12 mmol) and 1,3 diaminopropane (0.17 ml, 2 mmol) in presence of 
NaCNBH3 (1.2 equiv.) and ZnCl2 (1.2 equiv.) in methanol afforded a  precipitate. The latter 
was washed with deionized water and methanol. The resulting solid was suspended in 
methanol (5 mL), followed by the addition concentrated hydrochloric acid. All the solvent 
was removed by rotary evaporator and the solid obtained, was washed with diethyl ether to 
give 2e in 38% yield. 1HNMR: ((CD3)2SO +D2O solvent peak δ:2.51), (H2O, 4.03), 7.05-6.78 
(m, Ar-H, 12H), 3.99 (s, Ar-CH2-N, 8H), 3.76 (s, -OCH3, 12H), 2.96 (t, N-CH2-CH2, J = 2.4 
Hz, 4H), 1.98 (m, CH2-CH2-CH2, 2H). 13CNMR: ((CD3)2SO solvent peak δ: 39.8-38.6), 
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149.0-114.2, 56.1, 50.7, 43.8, 22.5. HRMS calcd for C35H44ClN2O8 [M-H2Cl]+ 619.3014, m/z 
found 619.3002 [M-H2Cl]+. 
Synthesis of 4,4',4'',4'''-((1,4-phenylenebis(azanetriyl))tetrakis(methylene))tetraphenol – 2f 
 The reaction between 4 hydroxybenzaldehyde (1.5 g, 12 mmol) and p-Phenylenediamine 
(0.2 g, 2 mmol) in methanol was evaporated to dryness. The resulting solid was washed 
thoroughly with water, chloroform and after drying, gave 2f in 66%. 1HNMR: ((CD3)2SO 
solvent peak δ:2.52-2.50), (H2O, 3.37), 9.23 (s, Ar-OH, 4H), 7.02-6.55 (m, Ar-H, 20 H), 4.27 
(s, Ar-CH2-N, 8H). 13CNMR: ((CD3)2SO solvent peak δ: 40.6-39.3), 156.5-115.5, 54.8. 
HRMS calcd for C34H33N2O4 [M+H]+ 533.2435, m/z found 533.2427. 
Synthesis of 4-((benzylimino)methyl)-2-methoxyphenol - 3 
Vanillin (1g, 6.6 mmol) was reacted with benzylamine (1.07 g, 10 mmol) in methanol 
overnight at room temperature. Once the reaction was completed, it was dissolved in 
chloroform followed by extraction with saturated NaHCO3 solution. The organic phase was 
collected, dried with anhydrous sodium sulphate and evaporated to dryness to afford 3 in 
63% yield. 1HNMR: (CDCl3 solvent peak δ:7.38), 8.32 (s, Ar-CH=N, 1H), 7.54-6.95 (m, Ar-
H, 8H), 4.85 (s, Ar-CH2-N, 2H), 3.93 (s, -OCH3, 3H). 13CNMR: (CDCl3 solvent peak δ: 77.4-
76.7), 161.8, 148.4-108.3, 64.9, 56.1. HRMS calcd for C15H16NO2 [M+H]+ 241.1176, m/z 
found 242.1170. 
Synthesis of 4-((benzylamino)methyl)-2-methoxyphenol – 4 
Compound 3 (0.7 g, 3 mmol) and sodium borohydride (0.11 g, 3 mmol) in methanol were 
stirred for 2 hours. Evaporation of the solvent yielded a solid which was washed thoroughly 
with deionized water and dried under vacuo to afford 4 in 68% yield as a pale yellow solid. 
1HNMR: ((CD3)2SO solvent peak δ:2.42-2.40), (H2O, 3.25), 7.33-6.62 (m, Ar-H, 8H), 3.86 (s, 
Ar-CH2-N, 2H), 3.65 (s, -OCH3, 3H), 3.55 (s, Ar-CH2-N, 2H). 13CNMR: ((CD3)2SO solvent 
peak δ: 40.6-39.4), 147.9-112.9, 56.0, 52.2. HRMS calcd for C15H18NO2 [M+H]+ 244.1332, 
m/z found 244.1333.  
Antioxidant activity 
DPPH Assay 
The ability of the new compounds to scavenge DPPH free radical was determined by 
following Payet et al. [23] procedure with minor modifications on a 96-well platform. A 
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dilution series of antioxidant ranging from 1.5 to 1000 µM was made in eppendorf tubes (1.5 
mL). Those solutions (50 µl) were transferred to the corresponding well while methanol (50 
µl) was used as negative control wells. Thereafter DPPH solution (100 µl, 0.1 mM) were 
added to each well and the 96-well plate was kept in the dark for 30 minutes after which the 
absorbance was measured at 517 nm using a Bio-Rad iMark microplate reader. 
 
FRAP Assay 
The reducing capacity of the new compounds was measured using FRAP assay following the 
method described by Firuzi et al. [25], with minor modifications on a 96-well plate. A 
dilution series of antioxidant and Trolox ranging from 500 to 5000 µM was made in 
eppendorf tubes, then each solution (10 µl) was pipetted in the corresponding well in a 96 
well-plate. FRAP reagent (190 µl), prepared by mixing 2.5 ml of 10 mM TPTZ solution (in 
40 mM  HCl), 2.5 ml of 20 mM FeCl3 (in deionized water) and 25 ml of 300 mM sodium 
acetate buffer (pH 3.6) was added in each well. The plate was stored in the dark for 30 
minutes before the absorbance was measured at 593 nm using a Bio-Rad iMark microplate 
reader. 
ORAC Assay 
The ability of the new compounds to prevent the oxidative degradation of the fluorescent 
molecule fluorescein was measured using ORAC assay following the methods described by 
Roy et al. [35] and Huang et al. [36] with minor changes on a black-walled 96-well plate. A 
dilution series of antioxidant and Trolox was made in eppendorf tubes. 25 µl of solution from 
each tubes were pipetted in the corresponding well in the plate whereas phosphate buffer (25 
µl, 75 mM,  pH 7.4) were transferred in the control wells. Fluorescein solution (150 µl, 25 
nM) were added in each well and the plate was incubated in the plate reader at 37 °C for 30 
minutes. Subsequently AAPH solution (25 µl, 0.15 M) was added in the positive control and 
in the antioxidant wells whereas phosphate buffer (25 µl) was pipetted in the negative control 
and the fluorescence was measured every 2 minutes over a period of 2 hours (485/20 nm 
excitation, 525/20 nm emission) using a BioTek Synergy HT microplate reader. 
 
DNA Damage Protection Assay 
The ability of the novel derivatives to prevent oxidative stress-mediated strand breakage in 
supercoiled DNA plasmid was measured following the method previously described by us 
[37] and others [38] with minor changes. 0.7% agarose gel (50 mL, TAE buffer). Gel red dye 
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(5 µl) was used as DNA stain. A dilution series of antioxidant was made in 6 different 
eppendorf tubes depending on their protective effect.  Plasmid pbr322 DNA was used (0.5 
µg/µl, PBS). 8 different solutions were prepared in eppendorf tubes; the negative control (1 
µl of DNA plasmid solution and 22 µl PBS); the positive control (1 µl of DNA plasmid 
solution, 14 µl of PBS and 8 µl of 10 mM AAPH solution) and the working solutions (1 µl of 
DNA plasmid solution, 6 µl of PBS, 8 µl of 10 mM AAPH solution and 8 µl of antioxidant 
solution at different concentrations (refer to SI for concentrations used for each compound). 
The tubes were incubated in the dark at 37°C for 1 hour. 2 µl of loading dye (0.5% 
bromophenol blue, 50% glycerol in deionized water) were added in each tube and mixed 
thoroughly. Finally, 10 µl of each solution was loaded in each well of the agarose gel (0.7%) 
and it was electrophoresed for 70 minutes at 80 volts. The gels were analysed with a Fusion 
FX7 system for chemiluminescence and fluorescence and a picture was taken with a high 
resolution camera system. 
 
 
 
Cell viability in the presence of H2O2 stressor using the MTT Cell Assay 
SH-SY5Y cells were seeded (7 x 103 cells/well) in a 96-well plate. After attachment (24 hr), 
cells were treated with different concentrations (0.1-200.0µM for 1b and 0.001-10.0µM for 
2c) of drug and incubated for 24 hours. Subsequently H2O2 solution (50 µl, 1.6 mM) were 
then added in the positive control and in the drug wells (to give a final concentration of 400 
µM) followed by incubation for another 24 hours. Then, all the solutions were pipetted off 
from all the wells and 100 µl of MTT solution (0.5 mg/ml) were added in each well. The 
plate was covered with aluminium foil and incubated for 4 hours at 37 ˚C. The solutions in 
each well were removed and 100 µl of DMSO were added in each well in order to dissolve 
the formazan crystals. After 20 minutes of gentle shaking, absorbance was measured at 490 
nm with a Bio-Rad iMark microplate reader. Cell viability was expressed as a percentage of 
the absorbance from control cells. 
 
Statistical analysis 
Data are shown as mean ± standard deviation (SD) and all the experiments were run at least 
in triplicate. Statistical analysis was performed using both Microsoft Excel 2013 and GRAPH 
PAD prism 4 using ONE WAY ANOVA and Bonferroni’s multiple comparison test. 
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Significant differences are labelled accordingly (ns- not significant, p<0.05*, p<0.01**, 
p<0.001 ***). 
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Abbreviations used 
AAPH- 2,2′-azobis (2-amidinopropane) dihydrochloride, AUC- area under the curve, BHA- 
butylhydroxyaniline, BHT- butylhydroxytoluene, DMSO- dimethyl sulfoxide, DPPH- 
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Methylthiazolyldiphenyl-tetrazolium bromide, ORAC- Oxygen radical absorbance capacity, 
PBS- phosphate buffer saline, ROS- Reactive oxygen species, TE- Trolox equivalent, TPTZ- 
2,4,6-tripyridyl-s-triazine. 
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Highlights 
• Facile synthesis of new Vanillin derivatives based on reductive amination reaction 
• High Anti-oxidant/radical scavenging properties of  most compounds when compared to 
parent compound vanillin 
• DNA protective properties of synthesised derivatives against free radical inducer  
• Cyto-protective activity of selected Vanillin derivatives against Oxidative damage 
 
• Potential platform for the development of antioxidant based therapeutics. 
 
